CSL:NYSECarlisle Companies Incorporated Analysis
Data as of 2026-08-25 - not real-time
$361.76
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Carlisle Companies Incorporated is bullish at $361.76, with short-term averages leading the long-term ones. Over a rolling month the price has gained 6.9%. With RSI at 49.1 the momentum picture is neutral, alongside a bearish MACD signal. Watch $320.23 as support and $393.30 as the nearer resistance level.
On valuation the read is fair — earnings multiple of 20.5 versus a 29.7 sector average, below the peer group. Analyst price targets sit 13.9% above the current price. Revenue is growing at 8.3% on a 14.2% profit margin. The 1.38% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 46.2%, a beta of 1.17 and a maximum drawdown of 25.4%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 5 out of 10.
On valuation the read is fair — earnings multiple of 20.5 versus a 29.7 sector average, below the peer group. Analyst price targets sit 13.9% above the current price. Revenue is growing at 8.3% on a 14.2% profit margin. The 1.38% dividend yield looks covered by current payout levels.
Risk comes out at 6 of a possible 10, a elevated reading. With 30-day volatility of 46.2%, a beta of 1.17 and a maximum drawdown of 25.4%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 5 out of 10.
Top Market Events
Carlisle CSL stock is upgraded to Buy after strong Q2 2026 results and ~19% undervaluation; see outlook,...Carlisle delivered a record quarter with EPS and revenue both topping expectations by double digits, while raising...Building envelope solutions provider Carlisle Companies NYSE:CSL announced better-than-expected revenue in Q2 CY2026,...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 349.96
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 20.5 versus sector average of 29.7
- Trading above the 200-day average of 349.96
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 20.5 versus sector average of 29.7
- Analyst targets imply +13.9% versus the current price
- Return on equity of 39.2%
Key Metrics & Analysis
Financial Health
Revenue Growth8.30%
Profit Margin14.21%
P/E Ratio20.5
ROE39.18%
ROA10.81%
Debt/Equity178.70
P/B Ratio8.9
Op. Cash Flow$1.0B
Free Cash Flow$669.7M
Industry P/E29.7
Technical Analysis
TrendBullish
RSI49.1
Support$320.23
Resistance$393.30
MA 20$370.71
MA 50$358.50
MA 200$349.96
MACDBearish
VolumeDecreasing
Fear & Greed Index93.23
Valuation
Fair Value$248.53
Target Price$412.14
Upside/Downside13.93%
GradeFair
TypeBlend
Dividend Yield1.38%
Risk Assessment
Beta1.17
Volatility46.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.